Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 82201-82250 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05589389
Meat and Dietary Pattern Study
NA
Active, not recruiting
60 participants
Started: Oct 26, 2022 · Completed: Jul 30, 2025
1 condition
2 sponsors
1 location
NCT05597358
Efficacy of High Intensity Laser for Provoked Vestibulodynia
NA
Active, not recruiting
142 participants
Started: Oct 26, 2022 · Completed: Nov 1, 2025
1 condition
5 sponsors
4 locations
NCT05237804
Evaluation of an Intervention to Reduce the Time to Treatment for TAVI Patients
NA
Active, not recruiting
748 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT05284747
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
PHASE4
Active, not recruiting
6,019 participants
Started: Oct 26, 2022 · Completed: May 29, 2027
4 conditions
2 sponsors
120 locations
NCT05377034
Multinational Phase II Trial to Compare Safety and Efficacy of SIRT (Y-90 Resin Microspheres) Followed by Atezolizumab Plus Bevacizumab, vs SIRT (SIRT-Y90) Followed by Placebo in Locally Advanced HCC Patients
PHASE2
Recruiting
100 participants
Started: Oct 26, 2022 · Completed: Jan 31, 2028
1 condition
4 sponsors
14 locations
NCT05337514
Voice-Activated Technology to Improve Mobility in Multimorbid, Frail, Homebound Older Adults (EngAGE)
NA
Active, not recruiting
137 participants
Started: Oct 26, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
1 location
NCT05363319
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
N/A
Recruiting
500 participants
Started: Oct 26, 2022 · Completed: Oct 30, 2028
1 condition
1 sponsor
48 locations
NCT05519865
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
PHASE2
Active, not recruiting
118 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT05734521
Avalglucosidase Alfa Pregnancy Study
N/A
Recruiting
100 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2032
2 conditions
1 sponsor
1 location
NCT05120271
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
PHASE1/PHASE2
Active, not recruiting
7 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2042
4 conditions
3 sponsors
8 locations
NCT05536141
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
PHASE1
Recruiting
302 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2027
2 conditions
1 sponsor
28 locations
NCT05481151
A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV
PHASE3
Active, not recruiting
111 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
23 locations
NCT05544929
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
PHASE1
Recruiting
180 participants
Started: Oct 26, 2022 · Completed: Sep 1, 2027
12 conditions
1 sponsor
19 locations
NCT05169515
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
PHASE1
Recruiting
121 participants
Started: Oct 26, 2022 · Completed: Mar 7, 2029
1 condition
1 sponsor
26 locations
NCT05638087
Dexamethasone Treatment for OSA in Children
PHASE3
Active, not recruiting
10 participants
Started: Oct 26, 2022 · Completed: Aug 30, 2025
1 condition
1 sponsor
1 location
NCT05031819
Managing Hypertension Among People Living with HIV
NA
Active, not recruiting
960 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT04597099
Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion
EARLY_PHASE1
Recruiting
10 participants
Started: Oct 26, 2022 · Completed: Oct 1, 2025
2 conditions
2 sponsors
1 location
NCT05458219
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
PHASE1
Recruiting
470 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
39 locations
NCT05549609
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
PHASE1/PHASE2
Recruiting
6 participants
Started: Oct 26, 2022 · Completed: Oct 31, 2025
1 condition
2 sponsors
4 locations
NCT06651242
Decision Support Intervention of Minor Cancer Patients and Their Parents
NA
Recruiting
80 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2027
5 conditions
1 sponsor
1 location
NCT05444270
Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer
NA
Recruiting
270 participants
Started: Oct 26, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05398991
Coronary Covered Stents Implantation for the Treatment of Coronary Artery Perforation
NA
Recruiting
28 participants
Started: Oct 26, 2022 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05340686
Braining- Aerobic Physical Activity As Add on Treatment in Bipolar Depression
NA
Active, not recruiting
54 participants
Started: Oct 26, 2022 · Completed: Apr 20, 2027
6 conditions
2 sponsors
1 location
NCT05616988
Metabolomic Evaluation of Psycho-surgical Synergy on Body Image Restoration After Breast Cancer
NA
Recruiting
80 participants
Started: Oct 26, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT04451265
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy
N/A
Recruiting
250 participants
Started: Oct 26, 2022 · Completed: Mar 31, 2028
1 condition
1 sponsor
3 locations
NCT05929976
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
N/A
Recruiting
4,900 participants
Started: Oct 26, 2022 · Completed: Oct 1, 2029
4 conditions
2 sponsors
8 locations
NCT05934825
Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa
PHASE1/PHASE2
Recruiting
30 participants
Started: Oct 26, 2022 · Completed: Oct 26, 2025
1 condition
1 sponsor
1 location
NCT05490433
Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction
NA
Recruiting
790 participants
Started: Oct 26, 2022 · Completed: Jun 30, 2032
1 condition
1 sponsor
14 locations
NCT05393401
Photoplethysmographic Measurements of Pulse Wave Velocity (PWV) and Blood Pressure (BP)
NA
Recruiting
27 participants
Started: Oct 25, 2022 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT05466214
Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools
NA
Recruiting
720 participants
Started: Oct 25, 2022 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT05620862
Phase I Dose Escalation and Pharmacokinetics Clinical Trial of Mitoxantrone Hydrochloride Liposome in Children With Relapsed and Refractory Lymphoma and Solid Tumors
PHASE1
Active, not recruiting
68 participants
Started: Oct 25, 2022 · Completed: Jun 1, 2025
1 condition
2 sponsors
1 location
NCT05008081
The CATALINA Study
N/A
Recruiting
1,000 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2026
1 condition
5 sponsors
18 locations
NCT05460416
Treatment Preventive for Pre-eclampsia by Acetylsalicylic Acid in Women Who Underwent Frozen Embryo Transfer
PHASE3
Recruiting
276 participants
Started: Oct 25, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT06617000
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
PHASE1
Recruiting
38 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
7 locations
NCT05596266
CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic Leukemia
PHASE1
Recruiting
20 participants
Started: Oct 25, 2022 · Completed: Oct 25, 2025
1 condition
2 sponsors
1 location
NCT05478213
Ventricular Tachycardia Mechanisms
NA
Recruiting
10 participants
Started: Oct 25, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
3 locations
NCT04953754
Melatonin and Vaccine Response, Immunity, and Chronobiology Study
NA
Active, not recruiting
200 participants
Started: Oct 25, 2022 · Completed: Jun 30, 2025
3 conditions
2 sponsors
1 location
NCT05507242
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
PHASE2
Recruiting
80 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2025
5 conditions
3 sponsors
2 locations
NCT05409976
The GORE® VIAFORT Vascular Stent IVC Study
NA
Active, not recruiting
112 participants
Started: Oct 25, 2022 · Completed: May 31, 2030
10 conditions
1 sponsor
17 locations
NCT05570708
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
NA
Enrolling by invitation
48 participants
Started: Oct 25, 2022 · Completed: Jun 1, 2029
1 condition
2 sponsors
1 location
NCT05323448
Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.
NA
Recruiting
100 participants
Started: Oct 25, 2022 · Completed: Feb 1, 2025
4 conditions
2 sponsors
1 location
NCT05555212
To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation
PHASE1
Recruiting
72 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05556239
STAY-STRONG Study of Exercise Training During Chemotherapy
NA
Active, not recruiting
42 participants
Started: Oct 25, 2022 · Completed: Sep 1, 2025
9 conditions
1 sponsor
1 location
NCT05625373
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
PHASE2/PHASE3
Recruiting
30 participants
Started: Oct 25, 2022 · Completed: Aug 30, 2024
1 condition
1 sponsor
1 location
NCT05461885
Value of Gym-based Exercise Training for Young Adults Receiving Antipsychotic Medication: The Vega Trial
NA
Active, not recruiting
400 participants
Started: Oct 25, 2022 · Completed: Jan 31, 2026
2 conditions
3 sponsors
4 locations
NCT05331144
Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)
PHASE2
Recruiting
180 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2027
4 conditions
4 sponsors
1 location
NCT05762900
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
PHASE2
Recruiting
65 participants
Started: Oct 25, 2022 · Completed: Oct 25, 2030
2 conditions
1 sponsor
1 location
NCT05599191
A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
PHASE3
Active, not recruiting
825 participants
Started: Oct 25, 2022 · Completed: May 28, 2026
2 conditions
1 sponsor
191 locations
NCT05504941
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
NA
Recruiting
15 participants
Started: Oct 25, 2022 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06178822
Towards Novel BIOmarkers to Diagnose SEPsis on the Emergency Room
N/A
Recruiting
3,300 participants
Started: Oct 25, 2022 · Completed: Oct 1, 2026
7 conditions
3 sponsors
3 locations
Previous
1
More pages
1642
1643
1644
1645
1646
1647
1648
More pages
2369
Next